Comment from Combination Products Coalition

Summary: The Combination Products Coalition, a group of drug, biological product, and medical device manufacturers, expresses support for the 2026 OCMO Guidance Agenda. They specifically highlight their interest in participating in the development of the Essential Drug Delivery Outputs for Devices (EDDO) guidance to ensure regulatory predictability.